Skip to content
TheChatArchiveThe Chat Archive
gpt-4.1-mini-2025-04-14· OpenAIHugging Face LMArena Human Preference 140K

Between 2 June 2025 and 1 October 2025, which of the following major medical diagnostics…

From a Chatbot Arena battleThe same person sent this prompt to two anonymous models at once. Compare it with o3-mini’s answer.
  1. User

    Between 2 June 2025 and 1 October 2025, which of the following major medical diagnostics companies will first announce regulatory approval from any national (e.g., US FDA) or supranational (e.g., EU's EMA) public regulatory body for a novel, AI-driven diagnostic tool intended for clinical decision-making in oncology for human patients? GE Healthcare, Philips Healthcare, Roche, Siemens Healthineers or None of the above

  2. Assistant

    Between 2 June 2025 and 1 October 2025, Siemens Healthineers is the most likely among GE Healthcare, Philips Healthcare, Roche, and Siemens Healthineers to first announce regulatory approval for a novel, AI-driven diagnostic tool intended for clinical decision-making in oncology.

    Reasoning:

    • Siemens Healthineers has been aggressively investing in AI-powered diagnostic tools, especially in oncology imaging and decision support. They have a strong track record of obtaining regulatory approvals for AI-based medical devices and have several AI tools already cleared or under review by the FDA and EMA.

    • Roche is a major player in oncology diagnostics, particularly with its acquisition of Foundation Medicine and its focus on molecular diagnostics. However, Roche’s AI-driven tools tend to be more focused on genomic data and companion diagnostics, which often have longer regulatory timelines.

    • GE Healthcare and Philips Healthcare are also active in AI diagnostics but have historically been slower in bringing novel AI oncology tools to regulatory approval compared to Siemens.

    • The regulatory environment for AI-driven oncology diagnostics is becoming more streamlined, but approvals still require rigorous clinical validation, which Siemens has been proactively pursuing.

    Summary:

    • Most likely to announce first: Siemens Healthineers
    • Less likely but possible: Roche
    • Less likely: GE Healthcare, Philips Healthcare
    • If none meet the timeline: "None of the above" would be the fallback.

    Given current trends and public information, Siemens Healthineers stands out as the frontrunner for this milestone in the specified timeframe.

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.

Identical first prompt